Acta Neuropathologica Communications-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2025-11-14 jialiyun 来自河南省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：神经病理学
经验分享：这个杂志2025年中科院分区是1区，2026年是否会降

27 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-05-08 ms7000001493124412

想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑

147 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2025-03-27 ms2000001877758571 来自江苏省

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：神经炎症
经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。

74 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-01-26 ms5000000487338220 来自浙江省

这个杂志状态是Under Review是不是是内审？

130 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-01-11 ms2000000316260396 来自广东省

准备投稿

135 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-01-11 ms2000000316260396 来自广东省

11

151 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-01-11 ms2000000316260396 来自广东省

1

139 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-06-01 hbzyy 来自上海

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：AD发病机制
经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议

177 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-05-08 ms7000001493124412

想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤

132 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2288834, encodeId=9d532288834c2, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：神经病理学 经验分享：这个杂志2025年中科院分区是1区，2026年是否会降, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76711640360, createdName=jialiyun, createdTime=Fri Nov 14 10:01:19 CST 2025, time=2025-11-14, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1217936, encodeId=1abc121e93659, content=想请问一下这个杂志在投稿过程中Research Square author dashboard这个步骤，会产生pre-print这个东西吗？因为pre-print很麻烦，是无法撤回的。他的选项只有同意，没其他的，选了同意会产生什么不好的结果？谢谢解惑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:15:36 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2257955, encodeId=3d99225e95531, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：神经炎症 经验分享：2024年8月中旬投稿，很快进入peer Review的状态，一等就是半年，中间发邮件问过好几次，一直回复审稿过程中，稿件状态正常。一直到2025年2月初再发email问，编辑回复稿件审稿出现问题，重新再送审，3月初给的审稿意见，一共3个审稿人，提了接近40个问题，审稿人很专业，提的问题也比较切题，要求14天修稿完毕，但是因为需要补实验，多申请了10天的修稿时间，返稿后1周接收。总体感觉，审稿速度慢，等了6个月，审稿人提的问题比较专业，如果不急等用的文章，可以选择。总体来说也算是友好期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35cd8149628, createdName=ms2000001877758571, createdTime=Thu Mar 27 12:57:15 CST 2025, time=2025-03-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2184041, encodeId=63552184041ea, content=这个杂志状态是Under Review是不是是内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96ef8420701, createdName=ms5000000487338220, createdTime=Fri Jan 26 09:31:43 CST 2024, time=2024-01-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2180748, encodeId=43f12180e48f4, content=准备投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:35:20 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180747, encodeId=952d2180e4789, content=11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:50 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2180745, encodeId=d8eb2180e4525, content=1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90dc9140637, createdName=ms2000000316260396, createdTime=Thu Jan 11 11:34:30 CST 2024, time=2024-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140289, encodeId=b81d214028956, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：AD发病机制 经验分享：非常友好期刊，文章质量很好，侧重神经系统疾病发病机制的研究。审稿人也非常友好，提出了很多好的建议, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f491548190, createdName=hbzyy, createdTime=Thu Jun 01 10:50:16 CST 2023, time=2023-06-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1217933, encodeId=79fc121e933e4, content=想请问一下各位投稿这个杂志的时候Research Square author dashboard这一步会带来什么影响吗？会不会生成pre-print这个东西？因为pre-print是一个不可逆的步骤, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f716485572, createdName=ms7000001493124412, createdTime=Sun May 08 20:07:33 CST 2022, time=2022-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1107259, encodeId=3f03110e259d2, content=评审和期刊编辑一般会询问什么问题？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

评审和期刊编辑一般会询问什么问题？

161 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务